STOCK TITAN

Biote Schedules First Quarter 2024 Financial Results Release and Conference Call

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Biote Corp. (Nasdaq: BTMD) announced the release of its first-quarter 2024 financial results on May 7, 2024, after the market closes. A conference call to discuss the results will be held at 5:00 p.m. ET on the same day.
Biote Corp. (Nasdaq: BTMD) ha annunciato la pubblicazione dei risultati finanziari del primo trimestre 2024 il 7 maggio 2024, dopo la chiusura del mercato. Si terrà una teleconferenza per discutere i risultati lo stesso giorno alle 17:00 ET.
Biote Corp. (Nasdaq: BTMD) anunció que publicará los resultados financieros del primer trimestre de 2024 el 7 de mayo de 2024, después del cierre del mercado. Se realizará una llamada de conferencia para discutir los resultados ese mismo día a las 5:00 p.m. ET.
Biote Corp. (Nasdaq: BTMD)은 2024년 1분기 재무 결과를 2024년 5월 7일 시장 종료 후 발표할 예정이라고 발표했습니다. 같은 날 오후 5시(동부시간)에 결과에 대해 논의하기 위한 컨퍼런스 콜이 열릴 예정입니다.
Biote Corp. (Nasdaq : BTMD) a annoncé la publication des résultats financiers du premier trimestre 2024 le 7 mai 2024, après la fermeture du marché. Une conférence téléphonique pour discuter des résultats aura lieu le même jour à 17h00 ET.
Biote Corp. (Nasdaq: BTMD) gab bekannt, dass die Finanzergebnisse des ersten Quartals 2024 am 7. Mai 2024 nach Börsenschluss veröffentlicht werden. Eine Telefonkonferenz zur Besprechung der Ergebnisse findet am gleichen Tag um 17:00 Uhr ET statt.
Positive
  • None.
Negative
  • None.

IRVING, Texas--(BUSINESS WIRE)-- biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the Company will provide first quarter financial results on Tuesday, May 7, 2024, after the close of the market. A conference call to discuss the firm’s results will be held at 5:00 p.m. ET. the same day.

Conference Call Details

The conference call may be accessed by dialing (844) 481-2820 (U.S toll-free) or (412) 317-0679 (International). The live webcast of the call can be accessed using the following link: biote Corp. First Quarter Earnings Call. A replay of the webcast will be available on the Events page of the Biote Investor Relations website, found here, shortly after the event concludes.

About Biote

Biote is transforming healthy aging through innovative, personalized hormone optimization and therapeutic wellness solutions delivered by Biote-certified medical providers. Biote trains practitioners to identify and treat early indicators of aging conditions, an underserved global market, providing affordable symptom relief for patients and driving clinic success for practitioners.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Some of the forward-looking statements can be identified by the use of forward-looking words. Statements that are not historical in nature, including the words “may,” “can,” “should,” “will,” “estimate,” “plan,” “project,” “forecast,” “intend,” “expect,” “hope,” “anticipate,” “believe,” “seek,” “target,” “continue,” “could,” “might,” “ongoing,” “potential,” “predict,” “would” and other similar expressions, are intended to identify forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual results or developments to differ materially from those expressed or implied by such forward-looking statements, including but not limited to: the success of our dietary supplements to attain significant market acceptance among clinics, practitioners and their patients; our customers’ reliance on certain third parties to support the manufacturing of bio-identical hormones for prescribers; our and our customers’ sensitivity to regulatory, economic, environmental and competitive conditions in certain geographic regions; our ability to increase the use by practitioners and clinics of the Biote Method at the rate that we anticipate or at all; our ability to grow our business; the significant competition we face in our industry; the impact of strategic acquisitions and the implementation of our growth strategies; our limited operating history; our ability to protect our intellectual property; the heavy regulatory oversight in our industry; changes in applicable laws or regulations; the inability to profitably expand in existing markets and into new markets; the possibility that we may be adversely impacted by other economic, business and/or competitive factors, including recent bank failures; and future exchange and interest rates. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and other risks and uncertainties described in the “Risk Factors” section of Biote’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and other documents filed by Biote from time to time with the Securities and Exchange Commission. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Biote assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Biote does not give any assurance that it will achieve its expectations.

Investor Relations:

Eric Prouty

AdvisIRy Partners

eric.prouty@advisiry.com

Media:

Press@biote.com

Source: biote Corp.

FAQ

When will Biote Corp. release its first-quarter 2024 financial results?

Biote Corp. (Nasdaq: BTMD) will release its first-quarter 2024 financial results on Tuesday, May 7, 2024, after the close of the market.

What time is the conference call to discuss Biote Corp.'s first-quarter results?

The conference call to discuss Biote Corp.'s first-quarter results will be held at 5:00 p.m. ET on Tuesday, May 7, 2024.

How can I access the conference call?

The conference call may be accessed by dialing (844) 481-2820 (U.S toll-free) or (412) 317-0679 (International). The live webcast of the call can be accessed using the following link: biote Corp. First Quarter Earnings Call.

Where can I find a replay of the conference call webcast?

A replay of the webcast will be available on the Events page of the Biote Investor Relations website shortly after the event concludes.

biote Corp.

NASDAQ:BTMD

BTMD Rankings

BTMD Latest News

BTMD Stock Data

168.89M
16.48M
9.09%
46.23%
2.46%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States of America
IRVING